Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the therapy itself caused any type of secondary cancer in the modified T cells, ...
3 天
Stockhead on MSNDr Boreham’s Crucible: FDA approval blasted this regenerative biotech higher in 2024 ...Fresh from FDA approval for its stem-cell product for paediatric graft-versus-host disease, Mesoblast is pursuing consent for ...
Within a large group of more than 700 patients treated with CAR T cell therapy, researchers found no evidence that the ...
The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果